Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma
Daniel Martin(Goethe University Frankfurt), Emmanouil Fokas(Düsseldorf University Hospital)
Cited by 8
Related Papers
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
|Journal of Clinical Oncology|2019|536
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
|JAMA Oncology|2021|349
International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer
|Nature Reviews Clinical Oncology|2021|242